Oxaliplatin, 5-FU, Folinic Acid as First-line Palliative Chemotherapy in Elderly Patients with Metastatic or Recurrent Gastric Cancer
In Sil Choi, Do-Youn Oh, Byoung-Su Kim, Keun-Wook Lee, Jee Hyun Kim, Jong-Seok Lee
Cancer Res Treat. 2007;39(3):99-103. Published online 2007 Sep 30 DOI: https://doi.org/10.4143/crt.2007.39.3.99
|
Citations to this article as recorded by
Fabrication and evaluation of smart pH/thermo dual-responsive injectable intratumoral in situ depot hydrogels for controlled 5-FU delivery
Samiullah Khan, Bangul Khan, Huan Li
Beni-Suef University Journal of Basic and Applied Sciences.2023;[Epub] CrossRef Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature
C. de la Fouchardiere, L. Decoster, E. Samalin, C. Terret, C. Kenis, J.P. Droz, C. Coutzac, E. Smyth
Cancer Treatment Reviews.2021; 100: 102289. CrossRef Fabrication, rheological analysis, and in vitro characterization of in situ chemically cross‐linkable thermogels as controlled and prolonged drug depot for localized and systemic delivery
Samiullah Khan, Naveed Akhtar, Muhammad Usman Minhas
Polymers for Advanced Technologies.2019; 30(3): 755. CrossRef pH/Thermo-Dual Responsive Tunable In Situ Cross-Linkable Depot Injectable Hydrogels Based on Poly(N-Isopropylacrylamide)/Carboxymethyl Chitosan with Potential of Controlled Localized and Systemic Drug Delivery
Samiullah Khan, Naveed Akhtar, Muhammad Usman Minhas, Syed Faisal Badshah
AAPS PharmSciTech.2019;[Epub] CrossRef CHEMOTHERAPY IN ELDERLY PATIENTS WITH STOMACH CANCER
O. A. Koroleva, L. M. Kogoniya, M. M. Byakhova, A. G. Titov
Malignant tumours.2018; 8(2): 64. CrossRef Safety and Efficacy of Dose-dense Chemotherapy with TCF Regimen in Elderly Patients with Locally Advanced or Metastatic Gastric Cancer
Wanda Liguigli, Gianluca Tomasello, Laura Toppo, Rossana Poli, Silvia Lazzarelli, Federica Negri, Bruno Perrucci, Alessandra Curti, Matteo Brighenti, Gianvito Donati, Morena Nazzari, Mario Martinotti, Marco Vismarra, Massimo Rovatti, Rodolfo Passalacqua
Tumori Journal.2017; 103(1): 93. CrossRef Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer
Ji-Won Kim, Keun-Wook Lee, Kyu-Pyo Kim, Ju Hyun Lee, Yong Sang Hong, Jeong-Eun Kim, Sun Young Kim, Sook Ryun Park, Byung-Ho Nam, Sang-Hee Cho, Ik-Joo Chung, Young Suk Park, Ho-Suk Oh, Myung-Ah Lee, Hye Jin Kang, Young Iee Park, Eun-Kee Song, Hye Sook Han,
The Oncologist.2017; 22(3): 293. CrossRef Facile synthesis of gold nanorods/hydrogels core/shell nanospheres for pH and near-infrared-light induced release of 5-fluorouracil and chemo-photothermal therapy
Hui Jin, Xifeng Liu, Rijun Gui, Zonghua Wang
Colloids and Surfaces B: Biointerfaces.2015; 128: 498. CrossRef Retracted Article: Facile synthesis of quantum dots/mesoporous silica/quantum dots core/shell/shell hybrid microspheres for ratiometric fluorescence detection of 5-fluorouracil in human serum
Rijun Gui, Ajun Wan, Hui Jin
The Analyst.2013; 138(20): 5956. CrossRef A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases
Vincenzo Catalano, Renato Bisonni, Francesco Graziano, Paolo Giordani, Paolo Alessandroni, Anna Maria Baldelli, Virginia Casadei, David Rossi, Stefano Luzi Fedeli, Silvia D’Emidio, Lucio Giustini, Giammaria Fiorentini
Gastric Cancer.2013; 16(3): 411. CrossRef FOLFOX-4 Combination Chemotherapy as a First-line Treatment in Patients with Advanced Gastric Cancer
Cheon Woo Lee, Moo-In Park, Seun Ja Park, Won Moon, Hyung Hun Kim, Hae Won Lee, Ki Hwan Ku, Bu Kyung Kim
Korean Journal of Medicine.2012; 82(1): 37. CrossRef Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes
In Sil Choi, Hye Seung Lee, Keun-Wook Lee, Haeryoung Kim, Ki Hwan Kim, Yu Jung Kim, Jee Hyun Kim, Woo Ho Kim, Jong Seok Lee
Medical Oncology.2011; 28(4): 991. CrossRef Biodegradable and thermo-sensitive chitosan-g-poly(N-vinylcaprolactam) nanoparticles as a 5-fluorouracil carrier
N. Sanoj Rejinold, K.P. Chennazhi, S.V. Nair, H. Tamura, R. Jayakumar
Carbohydrate Polymers.2011; 83(2): 776. CrossRef Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer
Han Jo Kim, Jun Young Eun, Young Woo Jeon, Jina Yun, Kyoung Ha Kim, Se Hyung Kim, Hyun Jung Kim, Sang-Cheol Lee, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu Taek Lee, Seong-Kyu Park, Jong-Ho Won, Dae Sik Hong, Hee Sook Park
Cancer Research and Treatment.2011; 43(3): 154. CrossRef Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy
Ki Hwan Kim, Keun-Wook Lee, Sun Kyung Baek, Hye Jung Chang, Yu Jung Kim, Do Joong Park, Jee Hyun Kim, Hyung-Ho Kim, Jong Seok Lee
Gastric Cancer.2011; 14(2): 130. CrossRef Oxaliplatin and Leucovorin Plus Fluorouracil Versus Irinotecan and Leucovorin Plus Fluorouracil Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Adenocarcinoma
Sun Hyung Kang, Jeong Il Kim, Hee Seok Moon, Seok Hyun Kim, Jae Kyu Sung, Byung Seok Lee, Hyun Yong Jeong
The Korean Journal of Gastroenterology.2010; 55(1): 26. CrossRef Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer
In Sil Choi, Keun-Wook Lee, Ki Hwan Kim, Yu Jung Kim, Jee Hyun Kim, Jong Seok Lee
Medical Oncology.2010; 27(3): 992. CrossRef Three-Weekly S-1 Monotherapy as First-Line Treatment in Elderly Patients with Recurrent or Metastatic Gastric Cancer
Joo Han Lim, Moon Hee Lee, Hyung Gil Kim, Yong Woon Shin, Hyeon Gyu Yi, Seok Hwan Shin, Yoon Seok Hur, Chul Soo Kim, Hye Jeong Chang
Gut and Liver.2010; 4(4): 503. CrossRef Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer
Hye Jin Kim, Keun-wook Lee, Yu Jung Kim, Do-youn Oh, Jee Hyun Kim, Seock-ah Im, Jong Seok Lee
Acta Oncologica.2009; 48(3): 385. CrossRef
|